JPH0223532B2 - - Google Patents

Info

Publication number
JPH0223532B2
JPH0223532B2 JP61058678A JP5867886A JPH0223532B2 JP H0223532 B2 JPH0223532 B2 JP H0223532B2 JP 61058678 A JP61058678 A JP 61058678A JP 5867886 A JP5867886 A JP 5867886A JP H0223532 B2 JPH0223532 B2 JP H0223532B2
Authority
JP
Japan
Prior art keywords
observed
neutral protease
administration
produced
symptoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61058678A
Other languages
English (en)
Japanese (ja)
Other versions
JPS62215533A (ja
Inventor
Shigemi Fujisaki
Takashi Fujisaki
Junichi Yoshida
Takahiro Fujisaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP61058678A priority Critical patent/JPS62215533A/ja
Publication of JPS62215533A publication Critical patent/JPS62215533A/ja
Publication of JPH0223532B2 publication Critical patent/JPH0223532B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP61058678A 1986-03-17 1986-03-17 膠原病又は関節リウマチの予防治療剤 Granted JPS62215533A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61058678A JPS62215533A (ja) 1986-03-17 1986-03-17 膠原病又は関節リウマチの予防治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61058678A JPS62215533A (ja) 1986-03-17 1986-03-17 膠原病又は関節リウマチの予防治療剤

Publications (2)

Publication Number Publication Date
JPS62215533A JPS62215533A (ja) 1987-09-22
JPH0223532B2 true JPH0223532B2 (enrdf_load_stackoverflow) 1990-05-24

Family

ID=13091227

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61058678A Granted JPS62215533A (ja) 1986-03-17 1986-03-17 膠原病又は関節リウマチの予防治療剤

Country Status (1)

Country Link
JP (1) JPS62215533A (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02292226A (ja) * 1989-05-08 1990-12-03 Shigemi Fujisaki 障害された神経細胞賦活予防治療剤
JP2673417B2 (ja) * 1994-08-03 1997-11-05 茂巳 藤崎 Ｂ型肝炎又はｃ型肝炎のウイルス性疾患の予防治療剤
CA2544156C (en) * 2003-10-29 2012-07-10 Altus Pharmaceuticals Inc. Non-pancreatic proteases for controlling plasma cholecystokinin (cck) concentration and for treating pain

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5826822A (ja) * 1981-08-10 1983-02-17 Kaken Pharmaceut Co Ltd 慢性腎炎治療剤

Also Published As

Publication number Publication date
JPS62215533A (ja) 1987-09-22

Similar Documents

Publication Publication Date Title
Coe et al. Cirrhosis associated with methotrexate treatment of psoriasis
CA2253593C (en) Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca)
JP3721196B2 (ja) 新生物疾患および自己免疫疾患の治療または予防のためのマグネシウムベースの製品の使用
WO1994022896A1 (fr) Ameliorant de la cholestase
CZ219399A3 (cs) Použití glukokortikoidů s minimálním systémovým účinkem pro přípravu léku
CN101945659A (zh) 肾上腺髓质素产生增强剂
Lopez et al. Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer
Erwteman et al. Interstitial pulmonary fibrosis: a new side effect of practolol
JPH07247215A (ja) 肉芽腫症性及び線維症性肺疾患の治療剤
JPH0462299B2 (enrdf_load_stackoverflow)
JPH0223532B2 (enrdf_load_stackoverflow)
McGraw et al. Sucralfate
JPS5942649B2 (ja) 重症筋無力症治療剤
Fosså et al. Recombinant interferon‐alpha combined with prednisone in metastatic renal cell carcinoma reduced toxicity without reduction of the response rate—a phase II study
EP0911026A1 (en) Creatine derivatives for asthma
Staley et al. VARIOUS METHODS OF ADMINISTERING 5-FLUOROURACIL1, 2
Wangel et al. Malabsorption syndrome associated with carcinoma of the bronchus
WO1999022748A1 (fr) Remedes pour la recto-colite hemorragique
JPH0156050B2 (enrdf_load_stackoverflow)
JP3877807B2 (ja) 口内炎治療・予防剤
EP4447988A1 (en) Compositions for treating autoimmune arthritis
Danhof Pentazocine effects on gastrointestinal motor functions in man.
JPS62198621A (ja) 制癌補助剤
Rolla et al. Bisphosphonate-induced bronchoconstriction in aspirin-sensitive asthma
CN115867302A (zh) 通过抑制白介素-6、TNF-α和其他细胞因子以及通过减少C-反应蛋白来预防和抑制COVID-19发病率和死亡率的方法和化合物

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term